Biohaven Statistics
Total Valuation
Biohaven has a market cap or net worth of $4.61 billion. The enterprise value is $4.26 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohaven has 101.12 million shares outstanding. The number of shares has increased by 29.45% in one year.
| Current Share Class | 101.12M |
| Shares Outstanding | 101.12M |
| Shares Change (YoY) | +29.45% |
| Shares Change (QoQ) | +7.53% |
| Owned by Insiders (%) | 11.54% |
| Owned by Institutions (%) | 81.87% |
| Float | 84.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 282.52 |
| PB Ratio | 13.69 |
| P/TBV Ratio | 15.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.89 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -265.45% and return on invested capital (ROIC) is -159.19%.
| Return on Equity (ROE) | -265.45% |
| Return on Assets (ROA) | -118.79% |
| Return on Capital (ROIC) | -159.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.37M |
| Employee Count | 239 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -525,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.39% in the last 52 weeks. The beta is 4.12, so Biohaven's price volatility has been higher than the market average.
| Beta (5Y) | 4.12 |
| 52-Week Price Change | +54.39% |
| 50-Day Moving Average | 49.11 |
| 200-Day Moving Average | 43.74 |
| Relative Strength Index (RSI) | 39.74 |
| Average Volume (20 Days) | 756,944 |
Short Selling Information
The latest short interest is 9.15 million, so 9.05% of the outstanding shares have been sold short.
| Short Interest | 9.15M |
| Short Previous Month | 8.98M |
| Short % of Shares Out | 9.05% |
| Short % of Float | 10.86% |
| Short Ratio (days to cover) | 9.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -848.89M |
| Pretax Income | -750.36M |
| Net Income | -804.34M |
| EBITDA | -841.60M |
| EBIT | -848.89M |
| Earnings Per Share (EPS) | -$9.36 |
Full Income StatementBalance Sheet
The company has $378.82 million in cash and $28.99 million in debt, giving a net cash position of $349.83 million or $3.46 per share.
| Cash & Cash Equivalents | 378.82M |
| Total Debt | 28.99M |
| Net Cash | 349.83M |
| Net Cash Per Share | $3.46 |
| Equity (Book Value) | 316.01M |
| Book Value Per Share | 3.33 |
| Working Capital | 288.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$526.59 million and capital expenditures -$4.47 million, giving a free cash flow of -$531.06 million.
| Operating Cash Flow | -526.59M |
| Capital Expenditures | -4.47M |
| Free Cash Flow | -531.06M |
| FCF Per Share | -$5.25 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |